Aman Kant
Corporate Officer/Principal en Invea Therapeutics, Inc. .
Cargos activos de Aman Kant
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Corporate Officer/Principal | 01/11/2021 | - |
Historial de carrera de Aman Kant
Estadísticas
Internacional
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Aman Kant
- Experiencia
